Clinical trials
Mouth Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 68 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 13 |
| Cairo University | 7 |
| Rigshospitalet, Denmark | 3 |
| Tata Memorial Hospital | 3 |
| Chang Gung Memorial Hospital | 2 |
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2 |
| The University of Hong Kong | 2 |
| Zhongnan Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mouth Neoplasms | 68 |
| Squamous Cell Carcinoma of Head and Neck | 15 |
| Head and Neck Neoplasms | 12 |
| Oropharyngeal Neoplasms | 12 |
| Hypopharyngeal Neoplasms | 10 |
| Laryngeal Neoplasms | 9 |
| Nasopharyngeal Neoplasms | 9 |
| Salivary Gland Neoplasms | 6 |
| Leukoplakia, Oral | 4 |
| Tongue Neoplasms | 4 |
Trials
Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.